id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4203-0001,FDA,FDA-2019-N-4203,"Bone, Reproductive and Urologic Drugs Advisory Committee; Notice of
Meeting; Establishment of a Public Docket; Request for Comments",Notice,Meeting,2019-09-24T04:00:00Z,2019,9,2019-09-24T04:00:00Z,2019-10-29T03:59:59Z,2019-10-30T01:02:29Z,2019-20656,0,0,0900006483fbc72a